News

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...
Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...
A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...
Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
Dr. Igor Koralnik, chief of neuroinfectious diseases and global neurology, joins Marie Saavedra to talk about the findings.
Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...
The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...
Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.
A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...